DeciBio's Joe Daccache, Ph.D. and Rebecca Bair are featured in Bioprocess Online's recent article "2023 ADC Roundup: A Year Of Collaboration And Licensing Deals." In this comprehensive piece, Joe and Rebecca Bair dive deep into the intricate details of the antibody-drug conjugates (#ADCs) landscape throughout 2023. Despite a challenging funding climate in biotech, 2023 witnessed a remarkable surge with 76 ADC deals, showcasing the resilience and vibrancy of the industry. From licensing agreements to collaborations and acquisitions, the article sheds light on the diverse transactions that shaped the year. Stay tuned for more exciting ADC content from DeciBio, including the results from the ADC 2024 Industry Outlook Survey. 🌐 Participate in the survey here: https://lnkd.in/e-nn3DEv Click here to access the full article: https://lnkd.in/e-63wYED #Biotech #Innovation #2023Roundup #precisionmedicine #therapeutics #infographic #pharmanews #biotechnews #targetedtherapy #2024outlook
Bioprocess Online appreciates Joe Daccache, Ph.D., Rebecca Bair, and all of team DeciBio for their hard work and biologics bullishness!